Abstract | OBJECTIVE: RESEARCH DESIGN AND METHODS: Individuals with type 1 diabetes (n = 103, age 6-72 years, mean HbA1c 7.3% [56 mmol/mol]) participated in a 6-week randomized crossover trial to evaluate the efficacy and safety of a Tandem Diabetes Care t:slim X2 pump with Basal-IQ integrated with a Dexcom G5 sensor and a predictive low- glucose suspend algorithm (PLGS) compared with sensor-augmented pump (SAP) therapy. The primary outcome was CGM-measured time <70 mg/dL. RESULTS: Both study periods were completed by 99% of participants; median CGM usage exceeded 90% in both arms. Median time <70 mg/dL was reduced from 3.6% at baseline to 2.6% during the 3-week period in the PLGS arm compared with 3.2% in the SAP arm (difference [PLGS - SAP] = -0.8%, 95% CI -1.1 to -0.5, P < 0.001). The corresponding mean values were 4.4%, 3.1%, and 4.5%, respectively, represent-ing a 31% reduction in the time <70 mg/dL with PLGS. There was no increase in mean glucose concentration (159 vs. 159 mg/dL, P = 0.40) or percentage of time spent >180 mg/dL (32% vs. 33%, P = 0.12). One severe hypoglycemic event occurred in the SAP arm and none in the PLGS arm. Mean pump suspension time was 104 min/day. CONCLUSIONS:
|
Authors | Gregory P Forlenza, Zoey Li, Bruce A Buckingham, Jordan E Pinsker, Eda Cengiz, R Paul Wadwa, Laya Ekhlaspour, Mei Mei Church, Stuart A Weinzimer, Emily Jost, Tatiana Marcal, Camille Andre, Lori Carria, Vance Swanson, John W Lum, Craig Kollman, William Woodall, Roy W Beck |
Journal | Diabetes care
(Diabetes Care)
Vol. 41
Issue 10
Pg. 2155-2161
(10 2018)
ISSN: 1935-5548 [Electronic] United States |
PMID | 30089663
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | © 2018 by the American Diabetes Association. |
Chemical References |
- Blood Glucose
- Hypoglycemic Agents
- Insulin
|
Topics |
- Adolescent
- Adult
- Aged
- Algorithms
- Blood Glucose
(analysis)
- Blood Glucose Self-Monitoring
(methods)
- Child
- Cross-Over Studies
- Diabetes Mellitus, Type 1
(blood, diagnosis, drug therapy)
- Drug Delivery Systems
- Female
- Humans
- Hypoglycemia
(blood, chemically induced, prevention & control)
- Hypoglycemic Agents
(administration & dosage)
- Insulin
(administration & dosage)
- Insulin Infusion Systems
- Male
- Middle Aged
- Monitoring, Ambulatory
- Young Adult
|